ASTRAZEN.BOASTRAZEN.BOBSE
Loading
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Revenue | 8,086 | 8,056 | 10,030 |
| Gross Profit | 4,780 | 4,481 | 5,777 |
| Operating Income | 1,163 | 697 | 1,489 |
| Net Income | 933 | 616 | 993 |
| EBITDA | 1,479 | 1,009 | 1,510 |
| EPS Diluted | 37.32 | 24.64 | 39.72 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Cash & Equivalents | 3,523 | 4,484 | 5,003 |
| Total Current Assets | 6,188 | 7,057 | 8,355 |
| Total Assets | 7,747 | 8,566 | 9,849 |
| Total Current Liabilities | 3,035 | 3,327 | 3,839 |
| Total Liabilities | 3,185 | 3,452 | 3,962 |
| Total Equity | 4,562 | 5,114 | 5,887 |
| Total Debt | 121 | 86 | 72 |
| Net Debt | -3,402 | -4,398 | -4,931 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Operating Cash Flow | 1,048 | 1,008 | 583 |
| Capital Expenditure | -77 | -96 | -85 |
| Free Cash Flow | 971 | 912 | 498 |
| Stock-Based Comp | 15 | 18 | 24 |
| Net Change in Cash | 2,688 | 961 | 519 |